Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing
Go back to Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 9.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.03 | 52 Week High | $9.23 | |||
| Open | $9.03 | 52 Week Low | $1.16 | |||
| Day High | $9.03 | P/E | N/A | |||
| Day Low | $9.03 | EPS | $-0.30 | |||
| Volume | 11,699 | |||||
